CANCER PAIN MANAGEMENT:
A COMPLETE PATIENT GUIDE

Cancer pain arises from multiple mechanisms — tumour infiltration of nerves, bone, or visceral organs; treatment-related inflammation or neuropathy; and procedural pain. Understanding the type of pain is the first step toward choosing the right management strategy.

“Uncontrolled pain is not an inevitable part of cancer — it is a medical failure that can and must be addressed.”

• Nociceptive Pain

  Caused by actual or threatened tissue damage — somatic (bone, muscle, skin) or visceral (internal organs). Typically described as aching, throbbing, or pressure. Generally responds well to opioid analgesia.

• Neuropathic Pain

  Caused by direct nerve damage from tumour compression, invasion, or treatment (chemotherapy-induced peripheral neuropathy, post-surgical nerve injury). Described as burning, shooting, or electric. Requires adjuvant medications beyond standard opioids.

The World Health Organization's three-step analgesic ladder has guided cancer pain management since 1986 and remains the foundation of global practice — providing a systematic approach to escalating pain treatment based on severity.

“The WHO ladder was designed for resource-limited settings but applies universally — start with the appropriate step, titrate to effect, and use adjuvants at every level.”

• Step 1: Mild Pain (NRS 1–3)

  Non-opioid analgesics: paracetamol (acetaminophen) 500–1000 mg every 4–6 hours, and/or NSAIDs (ibuprofen, naproxen, diclofenac) with gastroprotection. Add adjuvants (antidepressants, anticonvulsants) for neuropathic component at any step.

• Step 2–3: Moderate to Severe Pain (NRS 4–10)

  Step 2: weak opioids (codeine, tramadol) or low-dose strong opioids (morphine 5–10 mg). Step 3: strong opioids titrated to effect — oral morphine, oxycodone, hydromorphone, fentanyl patch, methadone. No ceiling dose for strong opioids in cancer pain except toxicity.

Understanding the scale of the problem and the effectiveness of available treatments puts individual pain management decisions in context.

• 55–66%Cancer patients who experience significant pain during treatmentPain is among the most prevalent and feared symptoms in cancer — occurring in the majority of patients at some point during their illness.
• 85–90%Patients whose pain can be controlled with WHO ladder approachEffective pain control is achievable in the vast majority of cancer patients using standard pharmacological approaches — most inadequate pain control reflects undertreatment rather than treatment failure.
• 40–50%Patients whose cancer pain is undertreated globallyDespite available treatments, a large proportion of cancer patients worldwide receive inadequate pain management due to opioid availability restrictions, prescriber hesitancy, and patient reluctance to take opioids.

This table covers the most widely used analgesic and adjuvant medications for cancer pain — with typical doses, indications, and key considerations.

Effective pain management starts with effective pain assessment. Patients who communicate their pain clearly and systematically receive better treatment than those who minimise or vaguely describe it.

1. 1

   Use a Numerical Rating Scale

   Rate your pain from 0 to 10 at every clinic visit: 0 = no pain, 10 = worst pain imaginable. Record pain at its worst, its average, and its best over the past 24 hours — these three numbers give your team a complete picture.

2. 2

   Describe the Pain Quality

   Is it constant or intermittent? Aching, burning, stabbing, or shooting? Does it radiate? Does it worsen with movement, eating, or position? Pain quality guides medication selection — burning/shooting suggests neuropathic, aching/constant suggests somatic.

3. 3

   Report Breakthrough Pain Separately

   Breakthrough pain — episodic flares above your background level — requires separate treatment with fast-onset short-acting analgesics (oral morphine solution, fentanyl buccal tablet). Tell your team how often and how severe these episodes are.

4. 4

   Report Side Effects of Current Medications

   Constipation, nausea, sedation, and confusion are the most common opioid side effects — all treatable. Do not tolerate side effects silently; report them so your team can adjust the dose or switch agents.

5. 5

   Ask Directly for Better Control

   If your pain score remains ≥4 after medication adjustment, explicitly ask: 'My pain is not controlled — what can be changed?' You have a right to adequate pain control. Palliative care referral should be considered when pain is refractory to primary team management.

For patients whose pain is not controlled by optimised pharmacological management, interventional pain techniques offer additional relief — often dramatically reducing opioid requirements.

Frequently Asked Questions

Common questions from patients and families about cancer pain management.

Continue exploring guides on supporting wellbeing and managing symptoms during cancer treatment.